Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 ...
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...
Heavy metal star Ozzy Osbourne reveals the date for his final show, which will also reunite the founding members of Black ...
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...
1d
Hosted on MSNDaniel Barenboim reveals he has Parkinson's diseaseThe world-renowned Israeli-Argentine pianist and conductor Daniel Barenboim revealed Thursday he is suffering from ...
The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
“He’s very happy to be coming back and very emotional about this," Sharon told The Sun. “Parkinson’s is a progressive disease ...
23h
US Weekly on MSNOzzy Osbourne Says He Can No Longer Walk Amid Battle With Parkinson’s DiseaseSharon Osbourne shared an update on Ozzy Osbourne’s battle with Parkinson’s disease before his final show with Black Sabbat ...
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results